B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: eJHaem, 3, 3, S. 739-747
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2022
- Event
-
Veröffentlichung
- (who)
-
Wiley
- (when)
-
2022
- Creator
-
Bock, Theresa
Bewarder, Moritz
Cetin, Onur
Fadle, Natalie
Regitz, Evi
Schwarz, Eva C.
Held, Jana
Roth, Sophie
Lohse, Stefan
Pfuhl, Thorsten
Wagener, Rabea
Smola, Sigrun
Becker, Sören L.
Bohle, Rainer Maria
Trümper, Lorenz
Siebert, Reiner
Hansmann, Martin-Leo
Pfreundschuh, Michael
Drexler, Hans G.
Hoth, Markus
Kubuschok, Boris
Roemer, Klaus
Preuss, Klaus‐Dieter
Hartmann, Sylvia
Thurner, Lorenz
- DOI
-
10.1002/jha2.475
- URN
-
urn:nbn:de:bvb:384-opus4-985097
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:53 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bock, Theresa
- Bewarder, Moritz
- Cetin, Onur
- Fadle, Natalie
- Regitz, Evi
- Schwarz, Eva C.
- Held, Jana
- Roth, Sophie
- Lohse, Stefan
- Pfuhl, Thorsten
- Wagener, Rabea
- Smola, Sigrun
- Becker, Sören L.
- Bohle, Rainer Maria
- Trümper, Lorenz
- Siebert, Reiner
- Hansmann, Martin-Leo
- Pfreundschuh, Michael
- Drexler, Hans G.
- Hoth, Markus
- Kubuschok, Boris
- Roemer, Klaus
- Preuss, Klaus‐Dieter
- Hartmann, Sylvia
- Thurner, Lorenz
- Universität Augsburg
- Wiley
Time of origin
- 2022
Other Objects (12)
Quantitative phosphoproteomics for studying B-cell receptor signaling in Burkitt’s lymphoma
NFATc1 as a Therapeutic Target in Burkitt’s Lymphoma
Regulation of necroptosis in Burkitt's lymphoma
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
Identification of Burkitt lymphoma vulnerabilities using RNAi
Identification of Burkitt lymphoma vulnerabilities using RNAi
NFATc1 as a therapeutic target in Burkitt’s lymphoma : = NFATc1 - ein Angriffspunkt zur Therapie des Burkitt-Lymphoms
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma
Burkitt lymphoma, hemostasis and intercellular matrix : Barbara Robert memorial
Gene expression profiling and immunoglobulin stereotypy in Burkitt lymphoma
Experience with provisional WHO‐entities large B‐cell lymphoma with IRF4‐rearrangement and Burkitt‐like lymphoma with 11q aberration in paediatric patients of the NHL‐BFM group
Panel sequencing of primary cutaneous B-cell lymphoma
Quantitative phosphoproteomics for studying B-cell receptor signaling in Burkitt’s lymphoma
NFATc1 as a Therapeutic Target in Burkitt’s Lymphoma
Regulation of necroptosis in Burkitt's lymphoma
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
Identification of Burkitt lymphoma vulnerabilities using RNAi
Identification of Burkitt lymphoma vulnerabilities using RNAi
NFATc1 as a therapeutic target in Burkitt’s lymphoma : = NFATc1 - ein Angriffspunkt zur Therapie des Burkitt-Lymphoms
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma
Burkitt lymphoma, hemostasis and intercellular matrix : Barbara Robert memorial
Gene expression profiling and immunoglobulin stereotypy in Burkitt lymphoma
Experience with provisional WHO‐entities large B‐cell lymphoma with IRF4‐rearrangement and Burkitt‐like lymphoma with 11q aberration in paediatric patients of the NHL‐BFM group
Panel sequencing of primary cutaneous B-cell lymphoma
Quantitative phosphoproteomics for studying B-cell receptor signaling in Burkitt’s lymphoma
NFATc1 as a Therapeutic Target in Burkitt’s Lymphoma
Regulation of necroptosis in Burkitt's lymphoma
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
Identification of Burkitt lymphoma vulnerabilities using RNAi
Identification of Burkitt lymphoma vulnerabilities using RNAi
NFATc1 as a therapeutic target in Burkitt’s lymphoma : = NFATc1 - ein Angriffspunkt zur Therapie des Burkitt-Lymphoms
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma
Burkitt lymphoma, hemostasis and intercellular matrix : Barbara Robert memorial
Gene expression profiling and immunoglobulin stereotypy in Burkitt lymphoma
Experience with provisional WHO‐entities large B‐cell lymphoma with IRF4‐rearrangement and Burkitt‐like lymphoma with 11q aberration in paediatric patients of the NHL‐BFM group